USPTO serial 79129105
PAVE ITS-MCI
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- DE JONGE, KATHLEEN
- Law office
- TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PAVE ITS-MCI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Protein in raw material form for scientific and medical research; enzymes for the brewing industry; enzymes for use in the textile industry; enzymes for use in the dairy industry; enzymes for use in the food industry; stain repellents for textiles; industrial chemicals; biochemical catalysts; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purpose; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes | SECTION 70 - CANCELLED | — |
| 005 | Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietary and nutritional supplements for medical use | SECTION 70 - CANCELLED | — |
| 042 | Technical research in field of medicines and pharmaceuticals; technical project studies in field of medicines and pharmaceuticals; research and development of new products for others; research in the field of environmental protection; scientific laboratory services; product quality testing; chemist services; chemical research; bacteriological research; biological research | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2023 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jul 20, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 3, 2015 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 12, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 12, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 31, 2014 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 15, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 15, 2014 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 12, 2013 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 12, 2013 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 5, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 18, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 16, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 16, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 16, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 15, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 9, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |